Vonoprazan prevents bleeding from endoscopic submucosal dissection-induced gastric ulcers

Summary Background Vonoprazan, a potassium‐competitive acid blocker, is expected to improve the healing of endoscopic submucosal dissection ( ESD )‐induced gastric ulcers compared with proton pump inhibitors ( PPI s). Aim To compare the healing status of ESD ‐induced gastric ulcers and the incidence of post‐ ESD bleeding between subjects treated with vonoprazan for 5 weeks and those treated with PPI s for 8 weeks. Methods Patients in the...